Dr. Friedman specializes in managing infectious diseases in immunocompromised hosts, particularly those who have had solid organ transplants, stem cell transplants, or have cancer. He is interested in evaluating patients before transplantation to help reduce infectious risks and in customizing preventive strategies. Additionally, he has both clinical and research interests in invasive fungal infections, studying the epidemiology of infections in transplant recipients and participating in clinical trials for novel antifungals.
Skin Lesions in a Kidney Transplant Recipient: Key to an Early Diagnosis.
Skin Lesions in a Kidney Transplant Recipient: Key to an Early Diagnosis. Transpl Infect Dis. 2026 Jul-Aug; 28(4):e70258.
PMID: 42237484
Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi.
Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi. Clin Microbiol Rev. 2026 Mar 12; 39(1):e0024225.
PMID: 41677277
Risk factors and outcomes of Pneumocystis jirovecii pneumonia in kidney transplant recipients: A case-control study of the United States Renal Data System.
Risk factors and outcomes of Pneumocystis jirovecii pneumonia in kidney transplant recipients: A case-control study of the United States Renal Data System. Am J Transplant. 2026 Apr; 26(4):870-879.
PMID: 41412483
The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention.
The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention. Open Forum Infect Dis. 2024 Jun; 11(6):ofae133.
PMID: 38887472